EU Business News: Orkla Acquires Healthspan, Bayer Invests Locally, Ipsen Targets Baltics
A round-up of the latest European consumer health business news: Norway's Orkla strengthens its supplements offering with acquisition of UK's Healthspan; Bayer makes investment commitment to German Consumer Health operation; and Ipsen strikes a deal to promote brands in the Baltics.
You may also be interested in...
Healthspan adds New Zealand blackcurrant supplement to Elite range; Lanes Health brings Nordic iron supplement to UK, A Vogel offers British consumers an eco-friendly eye dropper version of Pollinosan; and Dermal Laboratories launches Doublebase Once.
Bayer Consumer Health posted sales up 6.5% in 2021 as strong demand for supplements and successful launches helped it grow faster than the global market. The company believes it can deliver up to 5% sales growth in 2022 driven by the upcoming launch of Astepro Allergy in the US and the return of the cough & cold category.
EU Business News: GSK Consumer Gets New Name, Navamedic Strikes Ipsen Deal, Enzymatica Optimistic After Tough Year
Round-up of the latest European consumer health business news: GSK reveals name for standalone consumer health business will be Haleon; Norways' Navamedic strikes a distribution deal with Ipsen for select GI OTC products; and Sweden's Enzymatica hopeful that changed consumer behaviors will help its sales rebound in 2022.